WO2000007553A1 - Treatment of hair loss - Google Patents

Treatment of hair loss Download PDF

Info

Publication number
WO2000007553A1
WO2000007553A1 PCT/GB1999/002584 GB9902584W WO0007553A1 WO 2000007553 A1 WO2000007553 A1 WO 2000007553A1 GB 9902584 W GB9902584 W GB 9902584W WO 0007553 A1 WO0007553 A1 WO 0007553A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
aromatherapy
agustifolia
lavandula
acceptable diluent
Prior art date
Application number
PCT/GB1999/002584
Other languages
French (fr)
Inventor
Anthony Ormerod
Isabel Hay
Margaret Jamieson
Original Assignee
Aberdeen University
Grampian University Hospitals Nhs Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aberdeen University, Grampian University Hospitals Nhs Trust filed Critical Aberdeen University
Priority to AU52944/99A priority Critical patent/AU5294499A/en
Publication of WO2000007553A1 publication Critical patent/WO2000007553A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • the present invention relates to a composition and a method for use of the composition to treat the loss of hair on the scalp and facial hair.
  • hair includes, inter alia , hair grown on the scalp and all facial hair, such as eyebrows and beards.
  • Alopecia areata is an auto-immune disease which can be influenced by stress. It is a common condition affecting 1% of people in the Western world. It can cause a great deal of social and psychological distress and is often highly detrimental to the sufferers well-being and self esteem. It has also been found that patients with alopecia areata have an increased risk of developing a psychiatric illness.
  • alopecia areata The course of alopecia areata is unpredictable, but factors affecting prognosis are well established. A poor prognosis is indicated by the chronicity of the condition (>lyr) , associated auto-immune conditions, atopy and family history. Conventional treatments, such as steroid therapy, have limited success and some have unacceptable toxicity.
  • Hair loss can also be genetic and many men suffer from androgenetic baldness which is also known as male pattern baldness. In androgenetic baldness hair loss mainly occurs on the crown of the sufferers head.
  • An object of this invention is to provide an effective natural remedy which has negligible side effects for treatment of hair lost through an auto-immune disease or androgenic baldness.
  • a topically applicable composition comprising a combination of aromatherapy oils, characterised by an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
  • aromatherapy oil concentrates are present in the following percentages by volume:
  • the concentration of Thyme vulgaris by volume is 15 to 25%, more preferably the concentration of Thyme vulgaris by volume is 18 to 22%.
  • the concentration of Lavandula agustifolia by volume is 23 to 32%, more preferably the concentration of Lavandula agustifolia by volume is 26 to 30%.
  • the concentration of Rosmarinus officinalis by volume is 25 to 35%, more preferably the concentration of Rosmarinus officinalis by volume is 27 to 33%.
  • the concentration of Cedrus atlantica by volume is 17 to 27%, more preferably the concentration of Cedrus atlantica by volume is 20 to 25%.
  • the biologically acceptable diluent is a carrier oil.
  • the carrier oil comprises Jojoba oil and Grapeseed oil.
  • Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
  • the Jojoba oil and the Grapeseed oil are used together at ratios between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
  • aromatherapy oils produces a synergistic effect compared to the use of any single aromatherapy oil in the treatment of hair loss. As all the oils are natural they do not result in significant adverse side effects.
  • a topical composition for the treatment of hair particularly in alopecia areata or androgenetic baldness, characterised by an admixture of aromatherapy oils comprising; Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent, said oils being present in an effective amount to stimulate hair regrowth.
  • aromatherapy oil concentrates are present in the following percentages by volume:
  • the biologically acceptable diluent is a carrier oil.
  • the carrier oil comprises Jojoba oil and Grapeseed oil.
  • Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
  • the Jojoba oil and the Grapeseed oil are used together at a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
  • a method for the treatment of hair loss comprising applying to an effected area of hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
  • aromatherapy oil concentrates are present in the following percentages by volume:
  • the biologically acceptable diluent is a carrier oil.
  • the carrier oil comprises Jojoba oil and Grapeseed oil.
  • Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
  • the Jojoba oil and the Grapeseed oil are used together in a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
  • the combination of aromatherapy oils are massaged into the skin for at least 2 minutes.
  • the combination of aromatherapy oils are massaged into the skin for 2 to 5 minutes. Massaging the skin, by moving the skin over the bones, for at least two minutes ensures that all the oils in the diluent are rubbed into the skin.
  • a source of heat or a means to prevent heat loss such as a wet or dry warm towel, the combination of aromatherapy oils is further absorbed by the skin.
  • the method further comprises not washing the treated area until at least 2 hours after treatment. This is ensures sufficient absorption of the oils into the treated area.
  • a method for the treatment of hair comprising applying to an effected area of the hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
  • aromatherapy oil concentrates are present in the following percentages by volume:
  • the biologically acceptable diluent is a carrier oil.
  • the carrier oil comprises Jojoba oil and Grapeseed oil.
  • Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
  • the Jojoba oil and the Grapeseed oil are used together in a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the hair and/or skin without there being an excess of oil to rub in.
  • the combination of aromatherapy oils are massaged into the effected area of the hair and/or skin for at least 2 minutes.
  • the combination of aromatherapy oils are massaged into the effected area of hair and/or skin for 2 to 5 minutes. Massaging the hair/skin for at least two minutes ensures that all the admixture in the diluent is rubbed well thereinto.
  • a source of heat or a means to prevent heat loss such as a wet or dry warm towel, the combination of aromatherapy oils is further absorbed by the hair/skin.
  • the method further comprises not washing the treated area until at least 2 hours after treatment. This is ensures sufficient absorption of the oils into the treated area.
  • Figure 1 shows the scoring system used in a standardised professional photographic assessment.
  • Figure 2 shows a flow diagram of the subjects during the trial.
  • Figure 3 shows a graphical representation of the results of the photographic assessment using the scoring system in Figure 1.
  • Figure 4 shows a graphical representation of the results of the map tracing assessment.
  • Figure 5a-d shows various views of a subject's scalp three months after the start of treatment.
  • Figure 5e-h shows various views of a subject's scalp seven months after treatment.
  • the subjects in the test group were given an admixture of the following essential oils in Jojoba oil (5ml) and Grapeseed oil (20ml) :
  • Thyme vulgaris two drops, 88mg
  • Lavandula agustifolia three drops, 108mg
  • Rosmarinus officinalis three drops, 114mg
  • Cedrus atlantica two drops, 94mg
  • the subjects in the control group were given only Jojoba oil (5ml) and Grapeseed oil (20ml) .
  • the scalps of the subjects were assessed three times; before treatment and, 3 months and 7 months after treatment.
  • the scalps were assessed by three methods:
  • control group as detailed in Figure 2, could be explained by the fact that the volunteers became discouraged with the seven month protocol.
  • the control group's relative lack of response suggests that it is the specific admixture in the composition which gives rise to the stimulatory effect opposed to an effect arising from the effects of the diluent, the nightly massage or heat.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a topically applicable composition comprising a combination of aromatherapy oils, characterised by an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent and a method for using the composition to treat hair loss.

Description

Treatment of Hair Loss
The present invention relates to a composition and a method for use of the composition to treat the loss of hair on the scalp and facial hair.
Hereinafter the term hair includes, inter alia , hair grown on the scalp and all facial hair, such as eyebrows and beards.
Alopecia areata is an auto-immune disease which can be influenced by stress. It is a common condition affecting 1% of people in the Western world. It can cause a great deal of social and psychological distress and is often highly detrimental to the sufferers well-being and self esteem. It has also been found that patients with alopecia areata have an increased risk of developing a psychiatric illness.
The course of alopecia areata is unpredictable, but factors affecting prognosis are well established. A poor prognosis is indicated by the chronicity of the condition (>lyr) , associated auto-immune conditions, atopy and family history. Conventional treatments, such as steroid therapy, have limited success and some have unacceptable toxicity.
For over 100 years natural extracts have been used separately, inter alia , to promote hair growth. All evidence of increase in hair growth, to date, using any natural extract has been anecdotal.
There is, therefore, a need for an effective treatment of the skin and/or hair for sufferers of auto-immune diseases, such as alopecia areata, which results in hair loss.
Hair loss can also be genetic and many men suffer from androgenetic baldness which is also known as male pattern baldness. In androgenetic baldness hair loss mainly occurs on the crown of the sufferers head.
There are no universally effective treatments available to counteract the androgenetic baldness. In this connection, if men are embarrassed about their hair loss they can try, for example, wearing a hairpiece or having surgery to transplant the follicles from the back of the head to the crown.
However, hair pieces often do not look natural thus making it obvious to observers that the sufferer is wearing a hairpiece. In addition, the surgery, which is expensive, cannot be used on everyone and at best only leads to a 50% or less density of hair on the top of the head. Accordingly, there is an ongoing need for a treatment which could aid men with androgenetic baldness.
An object of this invention is to provide an effective natural remedy which has negligible side effects for treatment of hair lost through an auto-immune disease or androgenic baldness.
According to the first aspect of this invention there is provided a topically applicable composition comprising a combination of aromatherapy oils, characterised by an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
Preferably the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10 to 30% Lavandula agustifolia-17 to 37% Rosmarinus officinalis-20 to 40% Cedrus atlantica-13 to 33%.
In a preferred embodiment the concentration of Thyme vulgaris by volume is 15 to 25%, more preferably the concentration of Thyme vulgaris by volume is 18 to 22%. Preferably the concentration of Lavandula agustifolia by volume is 23 to 32%, more preferably the concentration of Lavandula agustifolia by volume is 26 to 30%. Conveniently the concentration of Rosmarinus officinalis by volume is 25 to 35%, more preferably the concentration of Rosmarinus officinalis by volume is 27 to 33%. In a preferred embodiment the concentration of Cedrus atlantica by volume is 17 to 27%, more preferably the concentration of Cedrus atlantica by volume is 20 to 25%.
Conveniently the biologically acceptable diluent is a carrier oil. Preferably the carrier oil comprises Jojoba oil and Grapeseed oil. Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
In a preferred embodiment the Jojoba oil and the Grapeseed oil are used together at ratios between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
This combination of aromatherapy oils produces a synergistic effect compared to the use of any single aromatherapy oil in the treatment of hair loss. As all the oils are natural they do not result in significant adverse side effects.
According to a second aspect of the invention there is provided the use in the manufacture of a topical composition for the treatment of hair, particularly in alopecia areata or androgenetic baldness, characterised by an admixture of aromatherapy oils comprising; Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent, said oils being present in an effective amount to stimulate hair regrowth.
Preferably the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10-30% Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33% .
Conveniently the biologically acceptable diluent is a carrier oil. Preferably the carrier oil comprises Jojoba oil and Grapeseed oil. Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
In a preferred embodiment the Jojoba oil and the Grapeseed oil are used together at a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
According to a third aspect of the invention there is provided a method for the treatment of hair loss, particularly alopecia areata or androgenetic baldness, comprising applying to an effected area of hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
Preferably the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10-30% Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33% .
Preferably the biologically acceptable diluent is a carrier oil. Conveniently the carrier oil comprises Jojoba oil and Grapeseed oil. Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
In a preferred embodiment the Jojoba oil and the Grapeseed oil are used together in a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the skin without there being an excess of oil to rub in.
Conveniently the combination of aromatherapy oils are massaged into the skin for at least 2 minutes. Preferably the combination of aromatherapy oils are massaged into the skin for 2 to 5 minutes. Massaging the skin, by moving the skin over the bones, for at least two minutes ensures that all the oils in the diluent are rubbed into the skin. By then applying a source of heat or a means to prevent heat loss, such as a wet or dry warm towel, the combination of aromatherapy oils is further absorbed by the skin.
In a preferred embodiment the method further comprises not washing the treated area until at least 2 hours after treatment. This is ensures sufficient absorption of the oils into the treated area.
According to a fourth aspect of the invention there is provided a method for the treatment of hair comprising applying to an effected area of the hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
Preferably the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10-30% Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40' Cedrus atlantica-13-33% .
Conveniently the biologically acceptable diluent is a carrier oil. Preferably the carrier oil comprises Jojoba oil and Grapeseed oil. Each aromatherapy oil constitutes 0.2%-0.01% v/v or 0.2%-0.01%w/v of the carrier oil, preferably 0.1%- 0.05%v/v or 0.12-0.06%w/v.
In a preferred embodiment the Jojoba oil and the Grapeseed oil are used together in a ratio between 1:9 and 3:7, respectively. If the carrier oils are present between these ratios the admixture is in a sufficient concentration to work effectively on the hair and/or skin without there being an excess of oil to rub in.
Conveniently the combination of aromatherapy oils are massaged into the effected area of the hair and/or skin for at least 2 minutes. Preferably the combination of aromatherapy oils are massaged into the effected area of hair and/or skin for 2 to 5 minutes. Massaging the hair/skin for at least two minutes ensures that all the admixture in the diluent is rubbed well thereinto. By then applying a source of heat or a means to prevent heat loss, such as a wet or dry warm towel, the combination of aromatherapy oils is further absorbed by the hair/skin.
In a preferred embodiment the method further comprises not washing the treated area until at least 2 hours after treatment. This is ensures sufficient absorption of the oils into the treated area.
The invention will now be described, by way of illustration only, with reference to the following example and the accompanying figures.
Figure 1 shows the scoring system used in a standardised professional photographic assessment.
Figure 2 shows a flow diagram of the subjects during the trial.
Figure 3 shows a graphical representation of the results of the photographic assessment using the scoring system in Figure 1.
Figure 4 shows a graphical representation of the results of the map tracing assessment.
Figure 5a-d shows various views of a subject's scalp three months after the start of treatment. Figure 5e-h shows various views of a subject's scalp seven months after treatment.
Example
84 subjects with alopecia areata were randomised into two groups; a control group and a test group.
The subjects in the test group were given an admixture of the following essential oils in Jojoba oil (5ml) and Grapeseed oil (20ml) :
Thyme vulgaris (two drops, 88mg) Lavandula agustifolia (three drops, 108mg) Rosmarinus officinalis (three drops, 114mg) Cedrus atlantica (two drops, 94mg)
The subjects in the control group were given only Jojoba oil (5ml) and Grapeseed oil (20ml) .
Each night the subjects were required to massage the oils into their scalp for at least 2 minutes. Thereafter they were required to wrap their head in a warm towel to encourage absorption of the oils.
The scalps of the subjects were assessed three times; before treatment and, 3 months and 7 months after treatment. The scalps were assessed by three methods:
1)A four point comparison scale a)vellus hair/no hair b) sparse pigmented/non-pigmented terminal hair c) terminal regrowth with patches of alopecia areata d) terminal regrowth in all areas.
2) standardised professional photographic assessment scored independently by two dermatologists, who were "blind" to the therapy administered. A scoring system as shown in Figure 1 was used.
3) A map was traced onto transparent film wherever the alopecia occurred in patches. These tracings were then transferred onto flat acetate sheets. A computer image analyser was then used to calculate the area of alopecia.
As seen in Figure 2, 84 subjects entered the trial, 68% of the control group and 81% of the active group completed the trial. The subjects were well matched for the important demographic indicators which might affect response to therapy, see Table 1.
Using the photographic assessment improvements were found to be significant (p=0.008 (3 2) ) see Table 2 in the test group. The degree of improvement in the active group was assessed by Mann-Whitney U test and was significant with p=0.05.
The results of the alopecia scale, which scored the degree of improvement (from 1 to 6), are illustrated in Figure 3.
The measurement of traced areas, which could only be performed in 32 subjects in the active group, showed a mean reduction in area affected of 103cm2 (±140 S.D.) compared with -1.8cm2 (±155 S.D.) in the control group, see Figure 4. This was significant with p=0.05.
The subject in Figure 5(a-h) showed an excellent response. As can be seen from Figure 5a-d the subject was significantly bald before treatment but after 7 months the subjects hair had started to regrow significantly.
The responses were variable but showed a clear and statistically significant advantage to treatment with this composition. It appears that the admixture in the composition has a synergistic effect over using any of the essential oils separately.
The higher dropout rate in the control group, as detailed in Figure 2, could be explained by the fact that the volunteers became discouraged with the seven month protocol. The control group's relative lack of response suggests that it is the specific admixture in the composition which gives rise to the stimulatory effect opposed to an effect arising from the effects of the diluent, the nightly massage or heat.
The method of using the professional photographs was more useful than using the subjective scales. The images were judged by "blind" professionals and showed good agreement.
There were no significant adverse effects resulting from this treatment compared to those expected during treatment by other therapies, such as diphencyprone or squaric acid dibutylester systemic or interlesional steroid injections. The overall improvement rate was 44% compared with 38% success rate in a study using diphencyprone by Shapiro et aI.,J of Invest. Dermatology, 1995 and Gordon et al., BR J Dermatology, 1996. Accordingly, this is a safer treatment with a higher success rate.
An incidental observation from the above study was that two patients both suffering from alopecia areata and androgenetic baldness, each showed an improvement in the areas of baldness resulting from alopecia areata and androgenetic baldness. Accordingly, the present composition could be useful in the treatment of androgenetic baldness. Table 1
Figure imgf000013_0001
Table 2
Figure imgf000013_0002

Claims

Claims
1) A topically applicable composition comprising a combination of aromatherapy oils, characterised by an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
2) A topical composition according to claim 1 wherein the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10-30% Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33% .
3) A topical composition according to either preceding claim wherein the biologically acceptable diluent is a carrier oil.
4) A topical composition according to claim 3 wherein the carrier oil comprises Jojoba oil and Grapeseed oil.
5) A topical composition according to claim 4 wherein the Jojoba oil and the Grapeseed oil are respectively present at a ratio between 1:9 and 3:7.
6) The use in the manufacture of a topical composition for the treatment of hair loss characterised by an admixture of aromatherapy oils Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica disposed in a biologically acceptable diluent said oils being present in an effective amount to stimulate hair regrowth. 7) The use according to claim 6 wherein the aromatherapy oil concentrates are present in the following percentages by volume:
Thyme vulgaris-10-30%
Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33%.
8) The use according to either claim 6 or 7 wherein the biologically acceptable diluent is a carrier oil.
9) The use according to claim 8 wherein the carrier oil comprises Jojoba oil and Grapeseed oil.
10) The use according to claim 9 wherein the Jojoba oil and the Grapeseed oil are respectively present at a ratio between 1:9 and 3:7.
11) A method for the treatment of hair loss comprising applying to an effected area of hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
12) A method according to claim 11 wherein aromatherapy oil concentrates are present in the following percentages by volume :
Thyme vulgaris-10-30% Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33%. 13) A method according to either claim 11 or 12 wherein the biologically acceptable diluent is a carrier oil.
14) A method according to claim 13 wherein the carrier oil comprises Jojoba oil and Grapeseed oil.
15) A method according to claim 14 wherein the Jojoba oil and the Grapeseed oil are respectively present at a ratio between the ratios 1:9 and 3:7.
16) A method according to any of claims 11 to 15 wherein the combination of aromatherapy oils are massaged into the effected are for at least 2 minutes.
17) A method according to any of claims 11 to 16 further comprising covering the effected area with a source of heat means to prevent heat loss.
18) A method for the treatment of hair comprising applying to an effected area of hair and/or skin a combination of aromatherapy oils characterised by; an admixture of Thyme vulgaris, Lavandula agustifolia, Rosmarinus officinalis and Cedrus atlantica in a biologically acceptable diluent.
19) A method according to claim 18 wherein the aromatherapy oil concentrates are present in the following percentages by volume :
Thyme vulgaris-10-30%
Lavandula agustifolia-17-37% Rosmarinus officinalis-20-40% Cedrus atlantica-13-33%.
20) A method according to either claim 18 or 19 wherein the biologically acceptable diluent is a carrier oil.
21) A method according to claim 20 wherein the carrier oil comprises Jojoba oil and Grapeseed oil.
22) A method according to claim 21 wherein the Jojoba oil and the Grapeseed oil are respectively present at a ratio between 1:9 and 3:7.
23) A method according to any of claims 18 to 22 wherein the combination of aromatherapy oils in the biologically acceptable diluent are massaged into an area of skin to be treated for at least 2 minutes.
24) A method according to any of claims 18 to 23 further comprising covering the effected area with a source of heat or means to prevent heat loss.
PCT/GB1999/002584 1998-08-05 1999-08-05 Treatment of hair loss WO2000007553A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU52944/99A AU5294499A (en) 1998-08-05 1999-08-05 Treatment of hair loss

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9816989.9 1998-08-05
GBGB9816989.9A GB9816989D0 (en) 1998-08-05 1998-08-05 Treatment of hair loss

Publications (1)

Publication Number Publication Date
WO2000007553A1 true WO2000007553A1 (en) 2000-02-17

Family

ID=10836708

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/002584 WO2000007553A1 (en) 1998-08-05 1999-08-05 Treatment of hair loss

Country Status (3)

Country Link
AU (1) AU5294499A (en)
GB (1) GB9816989D0 (en)
WO (1) WO2000007553A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158828A1 (en) * 2000-02-22 2001-09-01 Tobajas Maximo Gomez Cosmetic stimulation of hair growth and spread cosnists of application of e.g. scalp revitalisers and capillary vitamins under controlled conditions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2587208A1 (en) * 1985-09-19 1987-03-20 Scherninski Francois Lotion for combatting hair loss and promoting hair regeneration
FR2642966A1 (en) * 1989-02-10 1990-08-17 Carrichon Pascal Composition for application to the hair
CH682217A5 (en) * 1991-05-23 1993-08-13 Linda Singer Dolla Hair lotion comprising aq. alcoholic extract of natural plant material - and aromatic plant substances and prepn., for treating or preventing baldness
FR2710525A1 (en) * 1993-09-30 1995-04-07 Billon Andre Hair lotion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2587208A1 (en) * 1985-09-19 1987-03-20 Scherninski Francois Lotion for combatting hair loss and promoting hair regeneration
FR2642966A1 (en) * 1989-02-10 1990-08-17 Carrichon Pascal Composition for application to the hair
CH682217A5 (en) * 1991-05-23 1993-08-13 Linda Singer Dolla Hair lotion comprising aq. alcoholic extract of natural plant material - and aromatic plant substances and prepn., for treating or preventing baldness
FR2710525A1 (en) * 1993-09-30 1995-04-07 Billon Andre Hair lotion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158828A1 (en) * 2000-02-22 2001-09-01 Tobajas Maximo Gomez Cosmetic stimulation of hair growth and spread cosnists of application of e.g. scalp revitalisers and capillary vitamins under controlled conditions

Also Published As

Publication number Publication date
GB9816989D0 (en) 1998-09-30
AU5294499A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
DE69922819T2 (en) METHOD FOR THE PREVENTION AND TREATMENT OF STRIAE DISTENSAE AND ITS USE IN DERMATOLOGY
US5695748A (en) Composition and process for the treatment and restoration of hair
CN111973641A (en) Antidandruff compositions and methods of use thereof
US8337821B2 (en) Composition for treatment of hyperhidrosis
WO1997000686A9 (en) A non-invasive novel method of cosmetic lip augmentation
KR20040055713A (en) Composition and Preparing Method of Lotion which include Essential Oil Blend for Healing Mental Problem
JPH0676311B2 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for the treatment of skin wrinkles and hyperpigmentation.
WO2000007553A1 (en) Treatment of hair loss
EP0659080B1 (en) Method for the treatment of hair loss
CN113116761A (en) Oil control composition, application thereof and oil control nursing membrane
KR20200069711A (en) Scalp essences for scalp care
CN113730325B (en) Foundation suitable for oily sensitive skin and preparation method thereof
Sachdev et al. An open-label, single-center, safety and efficacy study of eyelash polygrowth factor serum
Rayner Cosmetic rehabilitation.
DE4401274A1 (en) Liq. agent for promoting and maintaining hair growth
JPH11269042A (en) Cosmetic for scalp and hair
Toshitani et al. A new apparatus for hair regrowth in male‐pattern baldness
Schmid et al. Exploratory evaluation of tolerability, performance, and cosmetic acceptance of dexpanthenol‐containing dermo‐cosmetic wash and sun‐care products for tattoo aftercare
Ross Primary cicatricial alopecia: clinical features and management
CA2194773A1 (en) Method and compound for the treatment of hair loss
Jordaan An approach to the diagnosis and management of patchy, non-scarring hair loss
WO2023182714A1 (en) Composition for improving scalp condition, comprising gluconolactone and climbazole as active ingredients
CN112704702B (en) Traditional Chinese medicine composition for treating scalp psoriasis and preparation method thereof
US20230372222A1 (en) Formulations and methods for treating hair
CA1238281A (en) Hair treating agent and method of treating hair

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase